Addus HomeCare (NASDAQ:ADUS) Rating Lowered to “Hold” at StockNews.com

StockNews.com downgraded shares of Addus HomeCare (NASDAQ:ADUS) from a buy rating to a hold rating in a report released on Wednesday morning.

A number of other equities analysts also recently commented on ADUS. Royal Bank of Canada reiterated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. JMP Securities initiated coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 target price for the company. Macquarie reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Trading Down 1.0 %

Addus HomeCare stock opened at $95.77 on Wednesday. Addus HomeCare has a twelve month low of $87.88 and a twelve month high of $136.72. The stock’s fifty day simple moving average is $122.60 and its 200-day simple moving average is $126.08. The firm has a market capitalization of $1.74 billion, a P/E ratio of 21.92, a P/E/G ratio of 1.41 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. Sell-side analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ADUS. Quarry LP purchased a new position in Addus HomeCare during the third quarter worth about $28,000. Natixis raised its holdings in Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after purchasing an additional 132 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after purchasing an additional 214 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its holdings in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.